Autoimmune hepatitis: an approach to disease understanding and management

Margaret Corrigan, Gideon M Hirschfield, Ye Htun Oo, David H Adams

Research output: Contribution to journalArticlepeer-review

20 Citations (Scopus)


INTRODUCTION: Autoimmune hepatitis is a chronic immune-mediated liver injury, frequently associated with progression to end-stage liver disease if untreated. Patients commonly present with hepatitis, positive immune serology, elevated immunoglobulins and compatible liver histology, in the absence of an alternative aetiology.

SOURCES OF DATA: Data for this review were obtained using PubMed.

AREAS OF AGREEMENT: Disease usually responds to steroids and azathioprine, and appears to be a manifestation of autoimmune predisposition triggered in genetically susceptible individuals exposed to likely environmental challenges. We provide an up-to-date approach to disease understanding and management along with the clinical approach to diagnosis and current treatment suggestions.

AREAS OF CONTROVERSY: Controversies such as second line therapies and novel markers of disease activity are introduced.

GROWING POINTS: Increased understanding of the immunoregulatory mechanisms behind autoimmune hepatitis has led to opportunities for new therapies. These are developed including a discussion of timely research studies relevant to future therapies for patients.

Original languageEnglish
Pages (from-to)181-91
Number of pages11
JournalBritish Medical Bulletin
Issue number1
Early online date20 May 2015
Publication statusPublished - Jun 2015

Bibliographical note

© The Author 2015. Published by Oxford University Press. All rights reserved. For permissions, please e-mail:


Dive into the research topics of 'Autoimmune hepatitis: an approach to disease understanding and management'. Together they form a unique fingerprint.

Cite this